Investor profile
Eli Lilly and Company
- Portfolio companies
- 1
- Known capital represented
- $60M
Capital represented is the total size of rounds in this ledger, not the investor's individual check size.
Known activity
Portfolio rounds
Lead and participating investments
- ParticipatingSuperluminal Medicines
Series B · Sep 3, 2026
$60M